DSP-2230

DSP-2230 Suppliers list
Company Name: Fujian boshi pharmaceutical technology co. LTD  Gold
Tel: 0595-22008920; 18120708884
Email: 393612455@qq.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Email: liming@bio-fount.com

DSP-2230 manufacturers

  • DSP-2230
  • DSP-2230 pictures
  • $64.00
  • 2026-08-15
  • CAS:1233231-30-5
  • Purity: 99.68%
  • Supply Ability: 10g
DSP-2230 Basic information
Product Name:DSP-2230
Synonyms:DSP-2230;DSP2230; DSP 2230; DSP-2230;Inhibitor,inhibit,Na+ channels,Sodium Channel,DSP 2230,Na channels,DSP2230,DSP-2230;Propanamide, 2-[[[3-cyclobutyl-5-(3,4,5-trifluorophenoxy)-3H-imidazo[4,5-b]pyridin-2-yl]methyl]amino]-, (2S)-;(2S)-2-({[3-cyclobutyl-5-(3,4,5-trifluorophenoxy)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}amino)propanamide;DSP-2230, 10 mM in DMSO
CAS:1233231-30-5
MF:C20H20F3N5O2
MW:419.4
EINECS:
Product Categories:
Mol File:1233231-30-5.mol
DSP-2230 Structure
DSP-2230 Chemical Properties
Boiling point 607.8±55.0 °C(Predicted)
density 1.53±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO:125.0(Max Conc. mg/mL);298.04(Max Conc. mM)
form Solid
pka15.94±0.50(Predicted)
color White to off-white
InChIKeyHHXCJIMPEJSJTG-JTQLQIEISA-N
SMILESC(N)(=O)[C@@H](NCC1=NC2=CC=C(OC3=CC(F)=C(F)C(F)=C3)N=C2N1C1CCC1)C
Safety Information
MSDS Information
DSP-2230 Usage And Synthesis
UsesDSP-2230 is a selective Nav1.7/Nav1.8 blocker, can be used to improve neuropathic pain[1][2][3].
IC 50Nav1.7; Nav1.8
References[1] Bagal SK, et al. Voltage gated sodium channels as drug discovery targets. Channels (Austin). 2015;9(6):360-6. DOI:10.1080/19336950.2015.1079674
[2] Sara Sabina Hadida-Ruah, et al. Sulfonamides as modulators of sodium channels.
[3] Matthew Alsaloum, et al. Status of peripheral sodium channel blockers for non-addictive pain treatment. Nat Rev Neurol. 2020 Dec;16(12):689-705. DOI:10.1038/s41582-020-00415-2
DSP-2230 Preparation Products And Raw materials
Tag:DSP-2230(1233231-30-5) Related Product Information
DSP-2230 (2R)-2-[[[3-Cyclobutyl-5-(3,4,5-trifluorophenoxy)-3H-imidazo[4,5-b]pyridin-2-yl]methyl]amino]propanamide Halofuginone Triamterene Carbamazepine VERATRIDINE